Member Info for LSBM

Indeed, the interview was enlightening, although, as you know, Cali is home to a sizeable innovative biotech industry, and many of the world's leading cancer research institutions are located in the state. There are many potentials if you refer to this list: https://biopharmguy.com/links/company-by-location-small-molecules.php. It may well be Treeline Biosciences as they were one to "bag the biggest private biotech investments in October 2024. Around the world, oncology and drug discovery players attracted the biggest funding rounds overall. " https://www.labiotech.eu/in-depth/biotech-investments-october-2024/. Kailera Therapeutics and Seaport Therapeutics were also mentioned and could also be our potential partners.

For those of you trying to get your head around the sort of licensing agreement structures possible for small-molecule assets. Have a look at this JP morgan report: https://www.jpmorgan.com/content/dam/jpmorgan/documents/cb/insights/outlook/jpm-biopharma-deck-q3-2024-final-ada.pdf

"Biologics and small molecules lead early-stage investment and licensing deal values"

Worth a read if you haven't already: https://www.lse.co.uk/news/MKS/top-news-uk-grocery-sales-up-as-christmas-spending-comes-early-zn3l48ixeet5ll0.html

"Christmas has come early"

"The fastest-growing retailer, however, was Ocado. Ocado sales rose 9.5% to GBP611 million and its market share improved to 1.8% from 1.7%."

Thanks Sadoldgit. The request for more safety data is no surprise, given the serious adverse effects and restrictions of use.

And we, Sareum, have invested in an Edison report due by the end of the month.

Positive news ahead of the investor conference on Thursday.

I agree, HBD, it seems like other sites also list tomorrow for the next earnings report.

According to Tradingview.com, Sareum's earnings report is due tomorrow. Is this in anticipation of more positive news?

A lot is happening for SP now, and it will attract new investors. To recap, Sareum’s safety profile outperforms others on the market, a major finding. Therefore, the extent of safety is being further developed with multiple indications. This could be to de-risk for licensees as mentioned in RNS or could be TO, valuation, or to fast-track, given that toxicity is an issue with these inhibitors. The assertion that this is better than first-in-class drugs is a major achievement, and MHRA and any partner will want clarity on indications.

Moreover, the preparations are strong for this molecule as the crystalised form of the compound is patent-protected in the largest markets worldwide. Why would you do this if you had doubts about its delivery and had seen any data to suggest otherwise? Non-dilutive funding has been secured through warrants. Hence, Sareum is well-placed to develop its compound and commercials.

Has anyone got any insight into what has sparked this drop today?

And that it was well-tested. It's rumoured to be released by end of this Year. Here's hoping this will move the SP up.

Directors talk interviews

sorry about the link for some reason, it wasn't hiding part of the link:

https://www.***************************/warpaint-london-ceo-samuel-bazini-on-record-growth-expansion-and-2025-outlook-lonw7l/4121171928

it's at ***************************

https://www.***************************/warpaint-london-ceo-samuel-bazini-on-record-growth-expansion-and-2025-outlook-lonw7l/4121171928

good breakdown on growth drivers. https://www.***************************/warpaint-london-ceo-samuel-bazini-on-record-growth-expansion-and-2025-outlook-lonw7l/4121171928

Perhaps we will also get an update within 48 hours due to their obligations to shareholders.

I agree; more details about the Aldi and US partnership are required. How many stores? If it's the entire estate, then this has effectively doubled their access to customers, and this, too, before the most significant gifting season.

Https://whatsnew2day.com/midas-tips-update-the-future-looks-bright-for-budget-makeup-brand-warpaint/

The price and subsequent price came down slightly. Unless there are late transactions at play in the background I can't see.

Those two 279.20k transactions can't be buys?